|Articles|June 26, 2006
Comparability of protein pharmaceuticals and the suitability of methods for secondary structure analysis
This article looks at comparability of pharmaceuticals, highlighting their importance to regulatory agencies and biopharm companies.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
3
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
4
How a “Plan, Prevent, Prove” Approach Helps Avoid Facility and Equipment Problems
5
